Volunteers for the coronavirus vaccine trials in Turkey are being closely monitored at every step, authorities say.
The phase 3 trials of the Chinese COVID-19 vaccine that began on September 15 are taking place in two stages.
They include high-risk health workers and medium-risk volunteers, according to information received by the Anadolu agency.
Vaccines are administered to volunteers at 25 centers in 12 provinces. A sample of 12,450 will be tested.
Volunteers were urged to continue to wear masks and maintain social distancing.
An interim evaluation report is prepared after the vaccination of 500 volunteers.
So far, no significant side effects have been reported. Some of the more common side effects are fatigue, headache, muscle pain, and fever.
During the trial, some of the volunteers received real vaccines and the rest received a placebo.
Volunteers who have received a placebo will then be vaccinated.
Side effects of the vaccine are recorded on daily cards. Antibody tests were also performed to determine if the virus had been contracted before the start of the trial. A PCR test was also performed to determine an existing virus.
The second dose of vaccine is given on the 14th day after the first vaccination.
Until day 28, volunteers will be monitored regularly. After that, they will receive a phone call every week for a year.
People who wish to volunteer can apply on https://covid19asi.calismasi.info or call 0850 811 18 80.
The Chinese vaccine can be given to people between the ages of 18 and 59.
After one year, regulatory authorities will decide on the vaccine for commercial use.
Turkey has so far reported nearly 488,000 coronavirus patients, more than 13,300 deaths and 396,227 recoveries.
The pandemic has claimed more than 1.45 million lives in 191 countries and regions since last December.
More than 62.37 million cases have been reported worldwide, with nearly 40 million recoveries, according to Johns Hopkins University.
While the United States, India and Brazil remain the most affected countries in terms of the number of cases, Europe is in the grip of a second wave of infections.
* Written by Gozde Bayar
The Anadolu Agency website contains only a portion of the stories offered to subscribers in the AA News Distribution System (HAS), and in summary form. Please contact us for subscription options.